Plus Therapeutics Inc

NASDAQ:PSTV   3:59:43 PM EDT
2.09
+0.04 (+1.95%)
Products

Plus Therapeutics Inc Entered Into A Master Services Agreement With Piramal Pharma Solutions

Published: 03/23/2021 11:46 GMT
Plus Therapeutics Inc (PSTV) - Plus Therapeutics Inc - Entered Into a Master Services Agreement With Piramal Pharma Solutions.
Plus Therapeutics - Master Services Agreement for Development, Manufacture, and Supply of Plus' Rhenium Nanoliposome Intermediate Drug Product.
Plus Therapeutics - Anticipates Msa Will Lead to Clinical & Commercial Supply Agreements for Drug Product at Appropriate Stage of Development.